Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14505099 | 0.99 | THRB (0.53) | THRBTSHRALDH1A1POLBHSD17B10 | |
| SCHEMBL10100417 | 0.94 | THRB (0.51) | THRBTSHRALDH1A1CA1CA2 | |
| SCHEMBL26703794 | 0.92 | TSHR (0.50) | THRBTSHRALDH1A1POLBHSD17B10 | |
| SCHEMBL4644865 | 0.92 | TSHR (0.46) | THRBTSHRALDH1A1POLBHSD17B10 | |
| SCHEMBL19856425 | 0.87 | THRB (0.40) | THRBTSHRALDH1A1POLBHSD17B10 | |
| SCHEMBL156498 | 0.86 | ALDH1A1 (0.42) | THRBTSHRALDH1A1POLBHSD17B10 | |
| SCHEMBL17123534 | 0.84 | TSHR (0.48) | THRBTSHRALDH1A1POLBHSD17B10 | |
| SCHEMBL244964 | 0.83 | THRB (0.46) | THRBTSHRALDH1A1POLBCA1 | |
| SCHEMBL21385260 | 0.83 | THRB (0.37) | THRBTSHRALDH1A1MEN1KMT2A | |
| SCHEMBL12099746 | 0.82 | THRB (0.53) | THRBTSHRALDH1A1POLBCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240180788-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION | TOKUYAMA DENTAL CORPORATION (JP) | 2024-06-06 | — | — | US | disclosed |
| EP-4310128-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION | Tokuyama Dental Corporation (JP) | 2024-01-24 | — | — | EP | disclosed |
| US-20230350294-A1 | Negative Photosensitive Resin Composition, Patterning Process, Interlayer Insulating Film, Surface Protection Film, And Electronic Component | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| CN-111936524-B | Photochromic curable composition | 株式会社德山 | 2022-09-23 | — | — | CN | disclosed |
| CN-111936524-A | Photochromic curable composition | 株式会社德山 | 2020-11-13 | — | — | CN | disclosed |
| US-8735462-B2 | Radical-polymerizable resin, radical-polymerizable resin composition, and cured material thereof | DAICEL CORPORATION (JP) | 2014-05-27 | — | — | US | disclosed |
| US-20130030078-A1 | RADICAL-POLYMERIZABLE RESIN, RADICAL-POLYMERIZABLE RESIN COMPOSITION, AND CURED MATERIAL THEREOF | DAICEL CORPORATION (JP) | 2013-01-31 | — | — | US | disclosed |
| EP-1591098-B1 | Cationically curable composition for dental use | TOKUYAMA CORP (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-7365106-B2 | Cationically curable composition for dental use | TOKUYAMA CORPORATION (JP) | 2008-04-29 | — | — | US | disclosed |
| US-7220530-B2 | Light sensitive planographic printing plate material | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-05-22 | — | — | US | disclosed |
| US-7220530-B2 | Light sensitive planographic printing plate material | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-05-22 | — | — | US | disclosed |
| US-20050250868-A1 | Cationically curable composition for dental use | TOKUYAMA CORPORATION (JP) | 2005-11-10 | — | — | US | disclosed |
| EP-1591098-A1 | Cationically curable composition for dental use | TOKUYAMA CORPORATION (JP) | 2005-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240180788-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION | CRY1, CRY2, TYR | THRB 4645/4885TSHR 4550/4885ALDH1A1 1497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.